positive biomarkers to select patients for bladder preservation in bladder cancer
Published 9 months ago • 103 plays • Length 1:44Download video MP4
Download video MP3
Similar videos
-
2:48
using biomarkers to identify bladder cancer patients for neoadjuvant therapy
-
1:08
the role of molecular biomarkers in determining patient response to bladder cancer treatment
-
1:25
bladder preservation vs radical cystectomy
-
1:25
overcoming challenges in localized bladder cancer management via biomarkers
-
2:35
genomic determinants of response to tmt for patients with muscle-invasive bladder cancer
-
4:19
novel biomarkers for outcomes identified in bcg-treated t1hg bladder cancer
-
2:51
deciding to choose cystectomy or bladder preservation in bladder cancer | backtable urology clips
-
18:50
the role of biomarkers in the diagnostic process of bladder carcinoma
-
1:06:18
biomarker-guided neoadjuvant therapy for bladder cancer
-
48:50
minimizing the impact of bladder cancer: organ preservation in male and female cystectomy
-
42:51
tumor centric- and liquid biomarkers for guiding treatment decisions in bladder cancer
-
0:54
dr. balar on biomarkers of immunotherapy response in bladder cancer
-
23:44
a review of aua/suo/astro guidelines for muscle invasive bladder cancer (mibc)
-
1:29:54
examining the state of the science on new therapies in bladder cancer
-
1:43
survivorship issues for patients with bladder cancer
-
4:43
imvigor011: atezolizumab for ctdna-positive patients with high-risk muscle invasive bladder cancer
-
2:41
should pd-l1 be used as a biomarker for immunotherapy in bladder cancer?
-
51:32
bladder preservation strategies for mibc - empire urology lecture series
-
19:21
immunotherapy for muscle invasive bladder cancer